Hebei Changshan Biochemical Pharmaceutical Co. Ltd. | Ownership
Companies that own Hebei Changshan Biochemical Pharmaceutical Co. Ltd.
Fullgoal Fund Management Co., Ltd.
8,800,000
1.48%
8,800,000
0.06%
09/30/2017
Rongtong Fund Management Co., Ltd.
3,739,548
0.63%
3,739,548
0.1%
12/31/2017
Harvest Fund Management Co., Ltd.
2,690,000
0.45%
2,690,000
0.01%
09/30/2017
GF Fund Management Co., Ltd.
292,700
0.05%
292,700
0%
12/31/2017
E Fund Management Co., Ltd.
281,143
0.05%
-2,700
0%
12/31/2017
FIAM LLC
274,235
0.05%
0
0%
07/31/2018
Huatai-PineBridge Fund Management Co., Ltd.
268,300
0.05%
268,300
0%
12/31/2017
China Southern Asset Management Co., Ltd.
123,763
0.02%
123,700
0%
12/31/2017
Truvalue Asset Management Co. Ltd.
85,800
0.01%
-55,200
0%
06/30/2017
Yinhua Fund Management Co., Ltd.
22,500
0%
22,500
0%
12/31/2017
About Hebei Changshan Biochemical Pharmaceutical Co.
View Profile
| Address |
North End of Yinchuan Avenue
Shijiazhuang Hebei 050800
China
|
|
Employees
|
- |
| Website |
http://www.heparin.cn |
| Updated |
07/08/2019 |
| Hebei Changshan Biochemical Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of heparin active pharmaceutical ingredient (API) and heparin preparations. Its products include heparin raw materials, heparin sodium injection, enoxaparin sodium API, heparin sodium raw materials, low molecular weight heparin calcium drug, enoxaparin sodium injection, and low molecular weight heparin calcium injection. The company was founded on September 28, 2000 and is headquartered in Shijiazhuang, China. |
